Retrospective multicentric study on Campylobacter spp. bacteremia in France: the Campylobacteremia study.

Claire TinévezFanny VelardoAnne-Gaëlle RancDamien DuboisHélène PailhorièsCyrielle CoddeOlivier Join-LambertEmmanuelle GrasStéphane CorvecCatherine NeuwirthCléa MelenotteMarie DorelAnne-Sophie LagneauxMaxime PichonViolaine DoatDamien FournierAdrien LemaignenLeslie BouardPierre PatozGenevieve Hery-ArnaudNadine LemaitreCélia CouzigouThomas GuillardElise RecaltEmmanuelle BilleYaniss BelaroussiDidier NeauCharles CazanavePhilippe LehoursMathilde Pugesnull null

Published in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2021)

Campylobacter spp. bacteremia mainly occurred in elderly immunocompromised individuals with variable clinical presentations according to the species involved. Appropriate antimicrobial therapy was associated with improved 30-day survival.

Keyphrases

biofilm formation
intensive care unit
escherichia coli
cross sectional
pseudomonas aeruginosa
mesenchymal stem cells
cystic fibrosis
middle aged
bone marrow
extracorporeal membrane oxygenation
respiratory failure
cell therapy
mechanical ventilation
genetic diversity